Integra Lifesciences (IART) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist

24.780
-0.730-2.86%

Close Nov 8 16:00 ET

24.500
-0.280-1.13%

Post 17:00 ET

1.91BMarket Cap-275333P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $26
Moomoo NewsNov 6 07:34 ET · Ratings
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $26
Moomoo NewsNov 5 15:31 ET · Ratings
Integra LifeSciences Price Target Raised to $26 From $21 at Truist
TipRanksNov 5 14:40 ET
Integra LifeSciences Is Maintained at Sell by Citigroup
Dow JonesNov 5 10:07 ET · Ratings
Integra Lifesciences Analyst Ratings
BenzingaNov 5 09:56 ET · Ratings
Morgan Stanley Remains a Sell on Integra Lifesciences (IART)
TipRanksNov 5 09:07 ET · Ratings

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.